eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Astellas Pharma Global Development, Inc. - Comment

Astellas Pharma Global Development, Inc. - Comment

Document ID: FDA-2012-N-0780-0008
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: October 04 2012, at 12:00 AM Eastern Daylight Time
Date Posted: October 19 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: August 14 2012, at 12:00 AM Eastern Standard Time
Comment Due Date: October 5 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 1jw-8180-2b0z
View Document:  View as format xml

View Comment

See attached file(s)

Attachments:

Astellas Pharma Global Development Inc Comment Regulatory New Drug Review Solutions for Study Data Exchange Standards

Title:
Astellas Pharma Global Development Inc Comment Regulatory New Drug Review Solutions for Study Data Exchange Standards

View Attachment: View as format pdf

Related Comments

    View All
Total: 30
Reengineering LLC - Comment
Public Submission    Posted: 09/05/2012     ID: FDA-2012-N-0780-0002

Oct 05,2012 11:59 PM ET
Novo Nordisk Inc - Comment
Public Submission    Posted: 10/17/2012     ID: FDA-2012-N-0780-0004

Oct 05,2012 11:59 PM ET
BioClinica - Comment
Public Submission    Posted: 10/19/2012     ID: FDA-2012-N-0780-0006

Oct 05,2012 11:59 PM ET
Duke University School of Medicine - Comment
Public Submission    Posted: 10/19/2012     ID: FDA-2012-N-0780-0007

Oct 05,2012 11:59 PM ET
Astellas Pharma Global Development, Inc. - Comment
Public Submission    Posted: 10/19/2012     ID: FDA-2012-N-0780-0008

Oct 05,2012 11:59 PM ET